Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H28N2O2.ClH |
| Molecular Weight | 316.867 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN(C)CCOCC(=O)NC12CC3CC(CC(C3)C1)C2
InChI
InChIKey=BPRCWSNCXPHMIW-UHFFFAOYSA-N
InChI=1S/C16H28N2O2.ClH/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16;/h12-14H,3-11H2,1-2H3,(H,17,19);1H
| Molecular Formula | C16H28N2O2 |
| Molecular Weight | 280.4057 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The susceptibility of magpies to a highly pathogenic avian influenza virus subtype H5N1. | 2010-06 |
|
| Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways. | 2010 |
|
| A critical role for endocytosis in Wnt signaling. | 2006-07-06 |
|
| [Clinical and epidemiological aspects and current recommendations on treatment of genital herpes]. | 2002-12 |
|
| Dimethyl sulfoxide blocks herpes simplex virus-1 productive infection in vitro acting at different stages with positive cooperativity. Application of micro-array analysis. | 2002-05-24 |
|
| Separation methods for tricyclic antiviral drugs. | 2001-11-25 |
|
| Contact dermatitis from topical antiviral drugs. | 2001-05 |
|
| Tromantadine: inhibitor of early and late events in herpes simplex virus replication. | 1982-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8494582
Unknown
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:34 GMT 2025
by
admin
on
Mon Mar 31 18:48:34 GMT 2025
|
| Record UNII |
H09LUS437B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
255-434-5
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | |||
|
SUB04992MIG
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | |||
|
C96719
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | |||
|
H09LUS437B
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | |||
|
DTXSID30194406
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | |||
|
236459
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | RxNorm | ||
|
41544-24-5
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | |||
|
m11220
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
170532
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY | |||
|
100000084671
Created by
admin on Mon Mar 31 18:48:34 GMT 2025 , Edited by admin on Mon Mar 31 18:48:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |